Picard Medical, Inc. has made a significant governance change by amending its bylaws to lower the quorum requirement for stockholder meetings. This decision, made by the company’s Board of Directors on October 7, 2026, aims to facilitate more efficient decision-making processes within the organization.
The amendment reduces the quorum requirement from a majority of the voting power of shares to thirty-three and one-third percent (33 1/3%). This change is particularly relevant as it aligns with the minimum quorum requirements set forth in Delaware General Corporation Law and the NYSE American Company Guide.
Background
Picard Medical, Inc. is a company operating in the surgical and medical instruments and apparatus sector, classified under SIC code 3841. The company is publicly traded on the NYSE under the ticker symbol PMI. The recent filing history includes multiple 8-K forms, indicating ongoing corporate activities and governance updates.
What the Filing Says
The filing states, "The Amendment amends Section 9 of the Amended and Restated Bylaws to decrease the quorum required for a meeting of the Company's stockholders." This change is effective immediately and is designed to streamline the process of holding meetings and making decisions.
Impact
This amendment may affect stockholders of Picard Medical, as it could lead to more frequent meetings and potentially quicker decision-making. The change may also influence how other companies in the surgical and medical instruments sector approach their governance structures, particularly in light of evolving corporate governance practices.
What's Next
The filing does not say what happens next.